Long CA - Search Results

1

Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.

Payne RO, Milne KH, Elias SC, Edwards NJ, Douglas AD, Brown RE, Silk SE, Biswas S, Miura K, Roberts R, Rampling TW, Venkatraman N, Hodgson SH, Labbé GM, Halstead FD, Poulton ID, Nugent FL, de Graaf H, Sukhtankar P, Williams NC, Ockenhouse CF, Kathcart AK, Qabar AN, Waters NC, Soisson LA, Birkett AJ, Cooke GS, Faust SN, Woods C, Ivinson K, McCarthy JS, Diggs CL, Vekemans J, Long CA, Hill AV, Lawrie AM, Dutta S, Draper SJ. Payne RO, et al. Among authors: long ca. J Infect Dis. 2016 Jun 1;213(11):1743-51. doi: 10.1093/infdis/jiw039. Epub 2016 Feb 4. J Infect Dis. 2016. PMID: 26908756 Free PMC article. Clinical Trial.

2

Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.

Wang R, Charoenvit Y, Daly TM, Long CA, Corradin G, Hoffman SL. Wang R, et al. Among authors: long ca. Immunol Lett. 1996 Nov;53(2-3):83-93. doi: 10.1016/s0165-2478(96)02610-7. Immunol Lett. 1996. PMID: 9024983

3

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.

Stowers AW, Cioce V, Shimp RL, Lawson M, Hui G, Muratova O, Kaslow DC, Robinson R, Long CA, Miller LH. Stowers AW, et al. Among authors: long ca. Infect Immun. 2001 Mar;69(3):1536-46. doi: 10.1128/IAI.69.3.1536-1546.2001. Infect Immun. 2001. PMID: 11179324 Free PMC article.

4

Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.

Hisaeda H, Saul A, Reece JJ, Kennedy MC, Long CA, Miller LH, Stowers AW. Hisaeda H, et al. Among authors: long ca. J Infect Dis. 2002 Mar 1;185(5):657-64. doi: 10.1086/339187. Epub 2002 Feb 14. J Infect Dis. 2002. PMID: 11865423

5

In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.

Kennedy MC, Wang J, Zhang Y, Miles AP, Chitsaz F, Saul A, Long CA, Miller LH, Stowers AW. Kennedy MC, et al. Among authors: long ca. Infect Immun. 2002 Dec;70(12):6948-60. doi: 10.1128/IAI.70.12.6948-6960.2002. Infect Immun. 2002. PMID: 12438374 Free PMC article.

6

Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.

Stowers AW, Kennedy MC, Keegan BP, Saul A, Long CA, Miller LH. Stowers AW, et al. Among authors: long ca. Infect Immun. 2002 Dec;70(12):6961-7. doi: 10.1128/IAI.70.12.6961-6967.2002. Infect Immun. 2002. PMID: 12438375 Free PMC article.

7

Biochemical and immunological characterization of bacterially expressed and refolded Plasmodium falciparum 42-kilodalton C-terminal merozoite surface protein 1.

Singh S, Kennedy MC, Long CA, Saul AJ, Miller LH, Stowers AW. Singh S, et al. Among authors: long ca. Infect Immun. 2003 Dec;71(12):6766-74. doi: 10.1128/IAI.71.12.6766-6774.2003. Infect Immun. 2003. PMID: 14638762 Free PMC article.

8

The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.

Darko CA, Angov E, Collins WE, Bergmann-Leitner ES, Girouard AS, Hitt SL, McBride JS, Diggs CL, Holder AA, Long CA, Barnwell JW, Lyon JA. Darko CA, et al. Among authors: long ca. Infect Immun. 2005 Jan;73(1):287-97. doi: 10.1128/IAI.73.1.287-297.2005. Infect Immun. 2005. PMID: 15618165 Free PMC article.

9

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A. Malkin EM, et al. Among authors: long ca. Vaccine. 2005 May 2;23(24):3131-8. doi: 10.1016/j.vaccine.2004.12.019. Vaccine. 2005. PMID: 15837212 Free PMC article. Clinical Trial.

10

posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

Giersing B, Miura K, Shimp R, Wang J, Zhou H, Orcutt A, Stowers A, Saul A, Miller LH, Long C, Singh S. Giersing B, et al. Infect Immun. 2005 Jul;73(7):3963-70. doi: 10.1128/IAI.73.7.3963-3970.2005. Infect Immun. 2005. PMID: 15972483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page